Menu

FORTIFY Clinical Trial

C:\Users\sharon.mcfadden\AppData\Local\Microsoft\Windows\INetCache\Content.Word\Fortify_CT_RGB.PNG

FORTIFY Clinical Trial:  A Prospective, Randomized Multicenter Controlled Trial of CERAMENT®|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures (NCT02820363)

The purpose of this study is to demonstrate the safety and effectiveness of CERAMENT®|G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone in the care of subjects with open fractures of the tibial diaphysis.*

This study is being conducted at hospitals in the United States and Europe. 

Principal Investigator:Douglas R. Dirschl, MD      

The University of Chicago Medicine

 

For More Information on participating centers, trial endpoints and inclusion criteria, visit https://clinicaltrials.gov/ct2/show/NCT02820363

*an open tibia (shinbone) fracture is one where the skin is broken and the bone is exposed to the outside